Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Predictability of Urinary CD80 in the Relapse of Primary Nephrotic Syndrome.

Liao J, Wu XC, Cheng Q, Li CL, Yi ZW, Cao Y, Shuai LJ.

Biomed Res Int. 2017;2017:9429314. doi: 10.1155/2017/9429314. Epub 2017 Aug 29.

2.

Complex glomerular pathology of thrombotic microangiopathy and focal segmental glomerulosclerosis forms tumor-like mass in a renal transplant donor with severe renovascular hypertension.

Nagata M, Yamaguchi Y, Toki D, Yamamoto I, Shinmura H, Kawaguchi H.

CEN Case Rep. 2017 May;6(1):12-17. doi: 10.1007/s13730-016-0235-0. Epub 2016 Sep 26.

3.

A case of the "cellular variant" of focal segmental glomerulosclerosis with acute renal failure that remitted completely with oral steroid administration.

Konno G, Someya G, Sekine K, Nishino T, Kawamoto S.

CEN Case Rep. 2012 Nov;1(2):77-81. doi: 10.1007/s13730-012-0017-2. Epub 2012 Jun 19.

4.

Idiopathic collapsing focal segmental glomerulosclerosis in an 81-year-old Japanese woman: a case report and review of the literature.

Yamazaki J, Kanehisa E, Yamaguchi W, Kumagai J, Nagahama K, Fujisawa H.

CEN Case Rep. 2016 Nov;5(2):197-202. doi: 10.1007/s13730-016-0224-3. Epub 2016 Jun 15.

5.

Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.

Laurin LP, Gasim AM, Derebail VK, McGregor JG, Kidd JM, Hogan SL, Poulton CJ, Detwiler RK, Jennette JC, Falk RJ, Nachman PH.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1752-1759. doi: 10.2215/CJN.13091215. Epub 2016 Jul 21.

6.

The Impact of Histologic Variants on FSGS Outcomes.

Meliambro K, Schwartzman M, Cravedi P, Campbell KN.

Int Sch Res Notices. 2014 Oct 29;2014:913690. doi: 10.1155/2014/913690. eCollection 2014. Review.

7.

FSGS: Diagnosis and Diagnostic Work-Up.

Sprangers B, Meijers B, Appel G.

Biomed Res Int. 2016;2016:4632768. doi: 10.1155/2016/4632768. Epub 2016 May 24. Review.

8.

Practical Application of Columbia Classification for Focal Segmental Glomerulosclerosis.

Han MH, Kim YJ.

Biomed Res Int. 2016;2016:9375753. doi: 10.1155/2016/9375753. Epub 2016 May 9. Review.

9.

Collapsing Glomerulopathy: A Single Centre Clinicopathologic Study of Seven Years.

Kanodia KV, Vanikar AV, Patel RD, Suthar KS, Nigam LK, Patel HV, Kute V, Trivedi HL.

J Clin Diagn Res. 2016 Apr;10(4):EC15-7. doi: 10.7860/JCDR/2016/17297.7646. Epub 2016 Apr 1.

10.

Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS.

Laurin LP, Gasim AM, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Foster BJ, Nachman PH.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):386-94. doi: 10.2215/CJN.07110615. Epub 2016 Feb 16.

11.

Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point.

Zhang BO, Cheng M, Yang M, Han S, Zhang YH, Shi HG, Zhu L, Zhao XZ.

Biomed Rep. 2016 Feb;4(2):147-152. Epub 2015 Dec 11.

12.

American Society of Nephrology Quiz and Questionnaire 2015: Glomerular Diseases.

Bomback AS, Perazella MA, Choi MJ.

Clin J Am Soc Nephrol. 2016 May 6;11(5):884-90. doi: 10.2215/CJN.12871215. Epub 2016 Feb 4. Erratum in: Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1513.

13.

Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab.

Ramachandran R, Rajakumar V, Duseja R, Sakhuja V, Jha V.

Clin Kidney J. 2013 Oct;6(5):500-2. doi: 10.1093/ckj/sft102. Epub 2013 Sep 5.

14.

Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.

Hara S, Kobayashi N, Sakamoto K, Ueno T, Manabe S, Takashima Y, Hamada J, Pastan I, Fukamizu A, Matsusaka T, Nagata M.

Am J Pathol. 2015 Aug;185(8):2118-31. doi: 10.1016/j.ajpath.2015.04.007. Epub 2015 Jun 11.

15.

Foam cells and the pathogenesis of kidney disease.

Eom M, Hudkins KL, Alpers CE.

Curr Opin Nephrol Hypertens. 2015 May;24(3):245-51. doi: 10.1097/MNH.0000000000000112. Review.

16.

Structural analysis of how podocytes detach from the glomerular basement membrane under hypertrophic stress.

Kriz W, Hähnel B, Hosser H, Rösener S, Waldherr R.

Front Endocrinol (Lausanne). 2014 Dec 12;5:207. doi: 10.3389/fendo.2014.00207. eCollection 2014.

17.

Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations.

Sethi S, Zand L, Nasr SH, Glassock RJ, Fervenza FC.

Clin Kidney J. 2014 Dec;7(6):531-7. doi: 10.1093/ckj/sfu100. Epub 2014 Sep 28.

18.

Causes and pathogenesis of focal segmental glomerulosclerosis.

Fogo AB.

Nat Rev Nephrol. 2015 Feb;11(2):76-87. doi: 10.1038/nrneph.2014.216. Epub 2014 Dec 2. Review.

19.

Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.

Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Zhao MH.

BMC Med. 2014 May 20;12:81. doi: 10.1186/1741-7015-12-81.

20.

Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients.

Kwon YE, Han SH, Kie JH, An SY, Kim YL, Park KS, Nam KH, Leem AY, Oh HJ, Park JT, Chang TI, Kang EW, Kang SW, Choi KH, Lim BJ, Jeong HJ, Yoo TH.

BMC Nephrol. 2014 Mar 25;15:52. doi: 10.1186/1471-2369-15-52.

Supplemental Content

Support Center